Cargando…

LRRK2 at the Crossroad of Aging and Parkinson’s Disease

Parkinson’s disease (PD) is a heterogeneous neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the widespread occurrence of proteinaceous inclusions known as Lewy bodies and Lewy neurites. The etiology of PD is still far...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hur, Eun-Mi, Lee, Byoung Dae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066012/ https://www.ncbi.nlm.nih.gov/pubmed/33805527 http://dx.doi.org/10.3390/genes12040505

Ejemplares similares

LRRK2 and membrane trafficking: nexus of Parkinson’s disease
por: Hur, Eun-Mi, et al.
Publicado: (2019)

Pathological Functions of LRRK2 in Parkinson’s Disease
por: Jeong, Ga Ram, et al.
Publicado: (2020)

Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson’s disease and beyond
por: Bae, Jae Ryul, et al.
Publicado: (2015)

LRRK2 and Proteostasis in Parkinson’s Disease
por: Pérez-Carrión, María Dolores, et al.
Publicado: (2022)

Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease
por: Lee, Byoung Dae, et al.
Publicado: (2010)

LRRK2 and the Endolysosomal System in Parkinson’s Disease
por: Erb, Madalynn L., et al.
Publicado: (2020)

The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
por: Russo, Isabella, et al.
Publicado: (2014)

Roco Proteins and the Parkinson’s Disease-Associated LRRK2
por: Liao, Jingling, et al.
Publicado: (2018)

LRRK2 and Lipid Pathways: Implications for Parkinson’s Disease
por: Galper, Jasmin, et al.
Publicado: (2022)

Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Parkinson's disease and mitophagy: an emerging role for LRRK2
por: Singh, Francois, et al.
Publicado: (2021)

LRRK2 Targeting Strategies as Potential Treatment of Parkinson’s Disease
por: Wojewska, Dominika Natalia, et al.
Publicado: (2021)

Contribution of GTPase activity to LRRK2-associated Parkinson disease
por: Tsika, Elpida, et al.
Publicado: (2013)

Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson’s Disease
por: Ito, Genta, et al.
Publicado: (2023)

Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration
por: Jeong, Ga Ram, et al.
Publicado: (2018)

LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
por: Chang, Eunice Eun Seo, et al.
Publicado: (2022)

The LRRK2–macroautophagy axis and its relevance to Parkinson's disease
por: Manzoni, Claudia
Publicado: (2017)

LRRK2 and Parkinson's disease: from genetics to targeted therapy
por: Sosero, Yuri L., et al.
Publicado: (2023)

LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
por: Pang, Shirley Yin-Yu, et al.
Publicado: (2022)

Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last Decade
por: Thakur, Gunjan, et al.
Publicado: (2022)

The Role of LRRK2 in Neurodegeneration of Parkinson Disease
por: Rui, Qin, et al.
Publicado: (2018)

Modeling Parkinson’s disease in LRRK2 rodents
por: Domenicale, Chiara, et al.
Publicado: (2023)

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
por: Atashrazm, Farzaneh, et al.
Publicado: (2016)

Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
por: Iseki, Tatou, et al.
Publicado: (2023)

An Update on the Interplay between LRRK2, Rab GTPases and Parkinson’s Disease
por: Komori, Tadayuki, et al.
Publicado: (2023)

Genetic Variants of LRRK2 in Taiwanese Parkinson’s Disease
por: Wu, Yih-Ru, et al.
Publicado: (2013)

A Link between Autophagy and the Pathophysiology of LRRK2 in Parkinson's Disease
por: Gómez-Suaga, Patricia, et al.
Publicado: (2012)

Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson's Disease
por: Rosenbusch, Katharina E., et al.
Publicado: (2016)

Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
por: Herrick, Mary K., et al.
Publicado: (2021)

LRRK2 in Parkinson's disease and dementia with Lewy bodies
por: Zhu, Xiongwei, et al.
Publicado: (2006)

Metabolomic Profiling in LRRK2-Related Parkinson's Disease
por: Johansen, Krisztina K., et al.
Publicado: (2009)

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
por: Bliederhaeuser, Corinna, et al.
Publicado: (2016)

Brain injury induces HIF-1α-dependent transcriptional activation of LRRK2 that exacerbates brain damage
por: Bae, Yun-Hee, et al.
Publicado: (2018)

Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism
por: Chittoor-Vinod, Vinita G., et al.
Publicado: (2021)

What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson’s Disease Patients and Healthy Subjects with Parkinson’s-Associated LRRK2 Mutations?
por: Loeffler, David A., et al.
Publicado: (2019)

Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s disease
por: Gonzalez-Hunt, C. P., et al.
Publicado: (2020)

Microtubule-Targeting Agents Enter the Central Nervous System (CNS): Double-edged Swords for Treating CNS Injury and Disease
por: Hur, Eun-Mi, et al.
Publicado: (2014)

Rare variants in LRRK1 and Parkinson's disease
por: Schulte, Eva C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_emhgsjdnlo0sum51t75388a1e6